Credo was overpriced even with great earnings, and it is still a little pricey at $190. Per @wallstengine, revenue rose 114.7% to $479.0M, beating estimates, and Q2 guidance of $525M-$535M also topped expectations, yet the stock is down $112 from its high of a few months ago. Valuation matters, and $150-$170 would be a decent entry point. x.com 

Credo's results were underwhelming for a company that added $32 billion in market value in a few months, and shorts may punish the stock. Per @WisemanCap, fiscal Q4 EPS of $1.16 beat the $1.02 estimate and revenue of $437 million was just above estimates, while Q1 fiscal 2027 revenue guidance of $465-476 million was roughly in line with the $464.7 million consensus. x.com  x.com 

Credo's near-total share of AI data-center cables and unchanged estimates make its lower multiple look like a fear-driven opportunity. Its stock went from 27x to 20x forward earnings while the supply chain building those systems guided 2027 revenue to double. Buyers this week will probably be very happy a year from now. x.com 

Credo is a trade rather than a long-term hold because co-packaged optics is the technology that closes the copper-to-optics gap its retimers and active electrical cables fill. If CPO ramps faster than expected in the 2027 architecture cycle, those products get designed out. That is not a 2026 problem, but it is why a decelerating hyper-growth chipmaker can't keep a 15x sales multiple forever. Customer concentration, which hit the stock before, adds risk, and Credo fits no AI endgame theme. x.com  … Show more

Credo is buying its re-acceleration at a flat gross margin, and at 36 times forward earnings, growth without margin is worth less. Q2 revenue guidance of $525-535M topped the $514.7M consensus, but non-GAAP gross margin went 68.6%, 68.3%, 68.0% and is guided at 67-69% again, while the beat over estimates shrank from 41% to 0.8%. Three customers are 77% of revenue. Credo sells copper, and Marvell expects scale-up optics from 2027. A print above 69% on $530M would prove this too cautious. x.com  … Show more

Credo is a great business on fire sale, with fundamentals unchanged since its valuation was stretched at 22x forward revenue in June. @TheBigBerbowski notes the stock is down 50% from its high even as revenue grew 114.7% to $479 million and non-GAAP net income rose 140%. The risk/reward is very attractive, and the shares could trade significantly higher in 6-12 months. x.com  x.com 

Credo's upside looks capped as growth falls short of earlier expectations and large stock-based compensation, hidden behind GAAP financials, looks excessive. BofA cut its target to $275 from $340 and Evercore to $292 from $325 on deceleration worries, the 1.6T DSP is delayed, and operating cash flow fell to $90M. The stock is 43% off its high; at $164 it trades at 30-33x FY27 earnings and 13x forward sales, more reasonable but still not worth owning. x.com  x.com  x.com  x.com 

Credo Technology's customer concentration is a hidden leverage risk investors underestimate. With four customers driving nearly all sales and two above 60%, Credo has little bargaining power if a hyperscaler demands lower prices, delays deployments, dual-sources or spends less, and any change could crush the stock. The AI boom hides this until growth normalizes. The business, economics and balance sheet are excellent and the valuation reasonable; much depends on how long the AI buildout lasts. … Show more

Credo looks cheap against its earnings at about 17.5x next year's EPS, versus the roughly 38x chipmakers usually get. At 38x the $9.63 forecast EPS, give or take 12%, fair value is about $322-410, leaving the stock near $168 about 48% below the low end. The view leans heavily on forecasts, as forward EPS is 284% above trailing, and it is a valuation-levels read rather than fundamental work. x.com 

Marvell looks attractive even on current guidance, which keeps rising as AI infrastructure demand may be outpacing long-term models. Its fiscal 2028 revenue target has climbed from $13 billion in September 2025 to $18 billion now, up 38% in under a year. With fiscal 2027 guided at $12 billion, the next six quarters imply $24.84 billion of revenue and, at a 31.6% non-GAAP net margin, $7.85 billion of earnings, so at $216.62 the stock trades at about 24 times that. x.com  x.com